Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Malignant Neoplasm of Gastrointestinal Tract”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Very early researchUnknownNCT04251403
What this trial is testing

Novel Approach to Surveillance of Gastric Lesions

Who this might be right for
Intestinal Metaplasia of Gastric MucosaGastric DysplasiaGastric Cancer+1 more
New York Presbyterian Hospital 10
Early research (Phase 1)Study completedNCT02860780
What this trial is testing

Prexasertib (LY2606368) in Combination With Ralimetinib in Participants With Advanced or Metastatic Cancer

Who this might be right for
Advanced CancerMetastatic CancerColorectal Cancer+1 more
Eli Lilly and Company 9
Early research (Phase 1)Study completedNCT03087591
What this trial is testing

APN401 in Treating Patients With Recurrent or Metastatic Pancreatic Cancer, Colorectal Cancer, or Other Solid Tumors That Cannot Be Removed by Surgery

Who this might be right for
Metastatic Malignant Neoplasm in the BrainMetastatic Solid NeoplasmRecurrent Colorectal Carcinoma+9 more
Wake Forest University Health Sciences 11
Testing effectiveness (Phase 2)Active Not RecruitingNCT02465060
What this trial is testing

Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)

Who this might be right for
Advanced LymphomaAdvanced Malignant Solid NeoplasmBladder Carcinoma+49 more
National Cancer Institute (NCI) 6,452
Not applicableEnded earlyNCT05368688
What this trial is testing

Microbiome in Colorectal Cancer Onset and Progression

Who this might be right for
Colorectal CancerTumorCRC+2 more
Viome 63
Testing effectiveness (Phase 2)Study completedNCT02845908
What this trial is testing

POF Versus FOLFOX Versus FOLFOX Plus ip Paclitaxel in AGC

Who this might be right for
Malignant Neoplasm of Stomach Stage IV
Fujian Cancer Hospital 90
Early research (Phase 1)Study completedNCT00397384
What this trial is testing

Erlotinib Hydrochloride and Cetuximab in Treating Patients With Advanced Gastrointestinal Cancer, Head and Neck Cancer, Non-Small Cell Lung Cancer, or Colorectal Cancer

Who this might be right for
Adenocarcinoma of the ColonAdenocarcinoma of the RectumAdvanced Adult Primary Liver Cancer+64 more
National Cancer Institute (NCI) 43
Testing effectiveness (Phase 2)Ended earlyNCT05451849
What this trial is testing

A Phase 1/2 Trial of TC-510 In Patients With Advanced Mesothelin-Expressing Cancer

Who this might be right for
MesotheliomaMesotheliomas PleuralMesothelioma, Malignant+14 more
TCR2 Therapeutics 14
Not applicableStudy completedNCT02192333
What this trial is testing

Survivorship Care in Reducing Symptoms in Young Adult Cancer Survivors

Who this might be right for
Breast CarcinomaCancer SurvivorDepression+10 more
Fred Hutchinson Cancer Center 390
Not applicableUnknownNCT04878185
What this trial is testing

Optimizing Physical Function Before Cancer Surgery in Older People at Risk

Who this might be right for
Colorectal CancerPostoperative Complications
Karolinska Institutet 53
Testing effectiveness (Phase 2)UnknownNCT02697838
What this trial is testing

Clinical Trial of Apatinib Reverses Chemotherapy-Resistance of Patients With Advanced Gastric Cancer

Who this might be right for
Malignant Neoplasm of Stomach Stage II
Fujian Cancer Hospital 20
Not applicableUnknownNCT03821025
What this trial is testing

Self-expandable Metal Stents Versus Multiple Plastic Stents for Palliation of Biliary Obstruction

Who this might be right for
Bile Duct Obstruction, ExtrahepaticCancer of the PancreasCancer of the Bile Duct+1 more
University of Cape Town 150
Not applicableLooking for participantsNCT05375643
What this trial is testing

SURGE: Supporting Utility and Representation in Genomics-based Cancer Trial Enrollment (Intervention)

Who this might be right for
Gastrointestinal CancerHematologic CancerThoracic Cancer
Nadine Jackson, MD, MPH 210
Not applicableUnknownNCT00716209
What this trial is testing

Infrastructure for Developing Gastrointestinal Cancer Prognostic and Predictive Markers

Who this might be right for
Gastrointestinal Cancer
Haematology-Oncology
Not applicableLooking for participantsNCT06971848
What this trial is testing

Evaluation of Skin Tests in Biotherapy Allergies

Who this might be right for
Locally Advanced Cutaneous Squamous Cell Carcinoma of the Head and NeckMelanoma NeoplasmsSmall Cell Bronchial Carcinomas+13 more
University Hospital, Angers 70
Not applicableStudy completedNCT02507414
What this trial is testing

Mesenteric Traction Syndrome During Upper Gastrointestinal Surgery

Who this might be right for
Gastrointestinal NeoplasmsMesenteric Traction Syndrome
Rigshospitalet, Denmark 75
Early research (Phase 1)Study completedNCT01843725
What this trial is testing

Phase 1 Study Testing the Combination of Aflibercept and Capecitabine in Metastatic Digestive and Breast Cancers

Who this might be right for
Metastatic Colorectal CancersMetastatic Gastric CancersMetastatic Oesophageal Cancers+3 more
Jules Bordet Institute 37
Testing effectiveness (Phase 2)UnknownNCT06046963
What this trial is testing

Sintilimab in Combination With S-1/Oxaliplatin With Nab-paclitaxel Intraperitoneal Infusion for Untreated Advanced Gastric Cancer With Malignant Ascites

Who this might be right for
Gastric CancerPeritoneal MetastasesAscites, Malignant
Zhejiang Cancer Hospital 35
Testing effectiveness (Phase 2)Looking for participantsNCT04278287
What this trial is testing

Chemoradiotherapy in Unresectable Esophageal Cancer

Who this might be right for
Esophageal CancerChemoradiotherapyAlbumin-bound Paxlitaxel+1 more
Cancer Institute and Hospital, Chinese Academy of Medical Sciences 105
Early research (Phase 1)Study completedNCT01325558
What this trial is testing

ALT-836 in Combination With Gemcitabine for Locally Advanced or Metastatic Solid Tumors

Who this might be right for
Locally Advanced Malignant NeoplasmMalignant Solid Tumour
Altor BioScience 30
Next Page